Skip to main content

Respiratory Syncytial Virus Topic Center

Featured Article

News
12/06/2024
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
11/22/2024
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the...
11/22/2024
Pharmacy Learning Network
News
11/08/2024
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
10/18/2024
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature...
10/18/2024
Pharmacy Learning Network
News
10/04/2024
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus...
10/04/2024
Pharmacy Learning Network
News
09/10/2024
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus...
09/10/2024
Pharmacy Learning Network
News
08/26/2024
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics...
08/26/2024
Pharmacy Learning Network
News
08/07/2024
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently...
08/07/2024
Pharmacy Learning Network
News
06/12/2024
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure...
06/12/2024
Pharmacy Learning Network
News
05/30/2024
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
Hospitalized older adults with...
05/30/2024
Pharmacy Learning Network
News
05/16/2024
Before the vaccine for respiratory syncytial virus (RSV), the virus was as severe as COVID-19 or influenza among unvaccinated patients, but more severe than COVID-19 or influenza among vaccinated patients hospitalized with those diseases,...
Before the vaccine for respiratory syncytial virus (RSV), the virus was as severe as COVID-19 or influenza among unvaccinated patients, but more severe than COVID-19 or influenza among vaccinated patients hospitalized with those diseases,...
Before the vaccine for...
05/16/2024
Pharmacy Learning Network

Newsfeed

News
12/06/2024
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
11/22/2024
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the...
11/22/2024
Pharmacy Learning Network
News
11/08/2024
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
10/18/2024
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature...
10/18/2024
Pharmacy Learning Network
News
10/04/2024
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus...
10/04/2024
Pharmacy Learning Network
News
09/10/2024
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus...
09/10/2024
Pharmacy Learning Network
News
08/26/2024
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics...
08/26/2024
Pharmacy Learning Network
News
08/07/2024
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently...
08/07/2024
Pharmacy Learning Network
News
06/12/2024
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure...
06/12/2024
Pharmacy Learning Network
News
05/30/2024
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
Hospitalized older adults with...
05/30/2024
Pharmacy Learning Network
Conference Coverage
12/11/2024
A study presented at the 2024 ASHP Midyear Clinical Meeting evaluated the impact of a pharmacist-led non-oncology infusion therapy management protocol, showing improvements in operational efficiency and other areas.
A study presented at the 2024 ASHP Midyear Clinical Meeting evaluated the impact of a pharmacist-led non-oncology infusion therapy management protocol, showing improvements in operational efficiency and other areas.
A study presented at the 2024...
12/11/2024
Pharmacy Learning Network
Conference Coverage
12/11/2024
Research at the 2024 ASHP Midyear Clinical Meeting suggests successful pharmacy technician outreach may improve medication adherence and outcomes for Medicare Advantage patients with historical adherence issues.
Research at the 2024 ASHP Midyear Clinical Meeting suggests successful pharmacy technician outreach may improve medication adherence and outcomes for Medicare Advantage patients with historical adherence issues.
Research at the 2024 ASHP...
12/11/2024
Pharmacy Learning Network
Conference Coverage
12/10/2024
At the 2024 ASHP Midyear Clinical Meeting, researchers presented on the impact of removing prior authorization (PA) restrictions on the utilization of sodium-glucose co-transporter-2 inhibitors (SGLT2i) in a primary care safety net clinic...
At the 2024 ASHP Midyear Clinical Meeting, researchers presented on the impact of removing prior authorization (PA) restrictions on the utilization of sodium-glucose co-transporter-2 inhibitors (SGLT2i) in a primary care safety net clinic...
At the 2024 ASHP Midyear...
12/10/2024
Pharmacy Learning Network
Conference Coverage
12/09/2024
Research at the 2024 ASHP Midyear Clinical Meeting explores pharmacists' evolving role in telepharmacy for chronic disease management, uncovering challenges and strategies to improve patient communication, optimize technology support, and...
Research at the 2024 ASHP Midyear Clinical Meeting explores pharmacists' evolving role in telepharmacy for chronic disease management, uncovering challenges and strategies to improve patient communication, optimize technology support, and...
Research at the 2024 ASHP...
12/09/2024
Pharmacy Learning Network
News
12/06/2024
JR Watkins is recalling thousands of cooling menthol extra-strength pain relief patches because of deviations from Current Good Manufacturing Practice (CGMP) regulations.
JR Watkins is recalling thousands of cooling menthol extra-strength pain relief patches because of deviations from Current Good Manufacturing Practice (CGMP) regulations.
JR Watkins is recalling...
12/06/2024
Pharmacy Learning Network
News
12/06/2024
Neogen Corporation is recalling several lots of LiceOut nonfoaming shampoo because of violations of Current Good Manufacturing Practice (CGMP) regulations.
Neogen Corporation is recalling several lots of LiceOut nonfoaming shampoo because of violations of Current Good Manufacturing Practice (CGMP) regulations.
Neogen Corporation is recalling...
12/06/2024
Pharmacy Learning Network
News
12/06/2024
Deviations from Current Good Manufacturing Practice (CGMP) regulations have prompted Unexo Life Sciences Private Limited to recall millions of over-the-counter pain relief patches sold by various distributors throughout the United States.
Deviations from Current Good Manufacturing Practice (CGMP) regulations have prompted Unexo Life Sciences Private Limited to recall millions of over-the-counter pain relief patches sold by various distributors throughout the United States.
Deviations from Current Good...
12/06/2024
Pharmacy Learning Network
News
12/06/2024
Deviations from Current Good Manufacturing Practice (CGMP) regulations have prompted Unexo Life Sciences Private Limited to recall millions of over-the-counter pain relief patches sold by various distributors throughout the United States.
Deviations from Current Good Manufacturing Practice (CGMP) regulations have prompted Unexo Life Sciences Private Limited to recall millions of over-the-counter pain relief patches sold by various distributors throughout the United States.
Deviations from Current Good...
12/06/2024
Pharmacy Learning Network
News
12/06/2024
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
12/04/2024
Medivant Healthcare is recalling syringes containing repackaged bevacizumab (Avastin) injection because of a lack of sterility assurance.
Medivant Healthcare is recalling syringes containing repackaged bevacizumab (Avastin) injection because of a lack of sterility assurance.
Medivant Healthcare is recalling...
12/04/2024
Pharmacy Learning Network